August 25, 2026, (Inside AI) — Unitree, China's best-known humanoid robot maker, has lost roughly 45% of its value since a spectacular Shanghai debut. The slump wiped about $30 billion from its peak valuation of $66 billion.
The reversal has triggered alarm over bubble risk, retail investor losses, and flaws in China's IPO system. Unitree shares steadied on Tuesday after three consecutive days of decline.
The wild swings raise a sharp question: has enthusiasm for AI and robotics outpaced fundamentals? Unitree's debut gain of 460% compared with an average first-day jump of 226% for Chinese listings over three years.
The company competes with Tesla and Hyundai Motor Group-owned Boston Dynamics. Yet Unitree's first-quarter adjusted net profit fell 53% to 40 million yuan ($5.95 million).
Its robots run, dance, and perform martial arts. But broader commercial applications remain elusive. The debut was not driven by strong earnings prospects, analysts said.
"Investors were carried away by the technology revolution narrative," said Dong Baozhen, chairman of Beijing-based asset manager Lingtong Shengtai, cautioning that "all bubbles are doomed to burst."
Unitree's fast-tracked listing on Shanghai's tech-focused STAR Market signaled government blessing. The board is reserved for hard-tech innovators in national strategic industries.
Investors saw perceived state support as China vies with the United States for tech supremacy. That belief fueled the frenzy.
China's IPO Loopholes Shift Risk to Retail Buyers #
Loopholes let major shareholders cash in while shifting risk to mom-and-pop investors, said Abraham Zhang, chairman of venture capital firm China Europe Capital.
"The debut performance was not fuelled by a rosy prospect, but a desire by some to pump up the shares so as to dump them later at lofty prices," Zhang said.
Regulatory paternalism and absent short-sellers mean overpriced listings face no immediate pushback, bankers said. That leaves small investors exposed.
"An IPO stock worth 10 yuan can open at 100 yuan, before sliding for years. It's a rip-off," said Yuan Yuwei, hedge fund manager at Trinity Synergy Investments.
Yuan noted pump-and-dump schemes are possible because short-selling is restricted. Investors chased Unitree and DRAM chipmaker CXMT because "there are not many good companies in China's stock market."
CXMT soared 466% in its Shanghai debut last month. Tight regulatory scrutiny limited Shanghai IPOs to just 21 companies in the first seven months, versus 104 in Hong Kong.
Dong said the gap between IPO price and debut performance means "either one of them must be wrong." He believes the debut was mispriced. "Debut performance is the barometer of market mood, and exuberant mood breeds bubbles."
A retail investor who lost money on Unitree wrote in a blog post that he supports Chinese innovation, but "the rapid concentration of wealth cannot be built on the pains of retail investors."
Those who won IPO shares "walked away with smiles," leaving many small investors in tears, Zhang said. "The capital drama seen in the Unitree listing is not the first in China, and will not be the last."
Patient Capital Versus Profit Pressure in Robotics #
Some fund managers urge patience. Gao Xingkun of China Southern Asset Management Co. drew a parallel to China's early electric vehicle industry.
"Many robot makers spend a lot on research, but commercial orders are not yet in sight," Gao said. "It's not fair if you only look at profit."
The Unitree case could become a cautionary tale for Chinese tech firms eyeing IPOs. It also shows the challenge Beijing faces in boosting strategic industries without market frenzy.
Unitree's reversal may set the tone for a slew of domestic rivals preparing to list. The sharp decline is a sign of market froth, not tech sector prosperity, analysts said.
The episode underscores a structural tension: China wants to fund hard-tech champions, but its IPO system can amplify speculative excess. Reforms may be needed to protect retail investors.
For now, Unitree's slide serves as a stark reminder that even state-backed robotics stars can fall hard when hype meets reality.